MedPath

StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood

Terminated
Conditions
Sepsis
Bleeding
Anemia
Erythrocytosis
Registration Number
NCT05118048
Lead Sponsor
Nova Biomedical
Brief Summary

The purpose of this study is to evaluate the clinical utility of the StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System in the testing of whole blood specimens from patients in hospital settings by CLIA waived operators, over a period of at least twenty days. The specimens shall include capillary (obtained by fingerstick), and venous whole blood. The study will also evaluate the use of a Fingerstick Blood Contamination Barrier for capillary sampling from the fingertip. This submission to the FDA is intended for a Point of Care (POC), CLIA waived device for whole blood capillary and venous lactate, and hemoglobin and hematocrit measurements.

Detailed Description

The study will be conducted at three (3) different healthcare settings (hereafter referred to as "testing sites") in POC sites/departments, by at least nine (9) CLIAW operators (at least 3 in each healthcare setting), over a period of at least twenty days at each healthcare setting. Examples of hospital departments include (but are not limited to) Emergency Department (ED), Intensive Care Unit (ICU), Pediatric Intensive Care Unit (PICU), Surgical Intensive Care Unit (SICU), Medical Intensive Care Unit (MICU), Cardiac Intensive Care Unit (CICU), Operating Room (OR), where point-of-care lactate, hemoglobin and hematocrit testing can be utilized.

Each site will recruit at least 120 patients for a total of 360 adult patients in all three (3) sites for each of the tests and specimen types. An attempt will be made to enroll 50% males and 50% females.

Each Study Subject will provide:

1. Two (2) capillary whole blood fingerstick specimens

1. One Lactate capillary test using the Fingerstick Blood Contamination Barrier

2. One Hb/Hct capillary test following traditional fingerstick protocol

2. One (1) venous whole blood specimen obtained by venipuncture collected in a lithium heparin tube or heparinized syringe:

1. One lactate venous test

2. One Hb/Hct venous test

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
285
Inclusion Criteria
  • Adult subjects (over or equal to 18 years old) with ordered hemoglobin and hematocrit
Exclusion Criteria
  • Pediatric

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analytical verification of StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System - Hematocrit comparison20 days

StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System, a point of care testing instrument is as effective as a reference laboratory method for Hematocrit blood results in %

Analytical verification of StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System - Lactate comparison20 days

StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System, a point of care testing instrument is as effective as a reference laboratory method for Lactate blood results in mmol/L

Analytical verification of StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System - Hemoglobin comparison20 days

StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System, a point of care testing instrument is as effective as a reference laboratory method for Hemoglobin blood results in g/dL

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Buffalo General Medical Center

🇺🇸

Buffalo, New York, United States

Erie County Medical Center

🇺🇸

Buffalo, New York, United States

Millard Fillmore Suburban Hospital

🇺🇸

Williamsville, New York, United States

© Copyright 2025. All Rights Reserved by MedPath